Qualitative and quantitative composition

dihydrochlorhydric Biscitate 0.9mg
Pharmaceutical form: lyophilized powder for injectable solution

Description and indication

As an adjunct to conventional CT or magnetic resonance imaging in the location of stroke in
patients in whom the stroke has already been diagnosed.
Presentation: 01 vial A and 01 vial B

Share

• Facebook
• Twitter
• Google plus